Objectives: To evaluate the impact of HIV infection on colonization resistance in the proximal gut.
Introduction
The human gut hosts trillions of microbes that outnumber the host cells by a factor of 10 and are known collectively as the gut microbiome. Whereas, the abundance of individual members can fluctuate within physiological ranges, the membership of gut microbiome is tightly controlled. Breach of this delicate equilibrium can result in opportunistic infections caused by either invasion of exogenous bacteria or outgrowth of certain endogenous bacteria. In contrast, classical infectious diseases often develop following exposure of susceptible hosts to pathogens such as Vibrio cholera in cholera and Bacillus anthracis in gastrointestinal anthrax. The mechanism that protects the host from invasion by exogenous bacteria is termed colonization resistance [1] . Endogenous bacteria can directly preclude exogenous bacteria from stable colonization by competing for essential nutrients [2] and mucosal attachment sites [3] , and by inhibiting the growth of exogenous bacteria through the secretion of bacteriocin [4] . Besides endogenous bacteria, the host immune system also plays a critical role in maintaining a stable microbiome. Adaptive immunity induced naturally or via vaccination reduces colonization by pathogenic Streptococcus pneumoniae by boosting both cellular and humoral immunity [5, 6] . Complex cooperation between commensal bacteria and host innate immunity governs the homeostasis of the gut microbiota [7] , as exemplified in a recent study that enterocytes promote colonization resistance against an intestinal opportunistic bacterium, Enterococcus faecalis via epithelial IL-22RA1-mediated fucosylation [8] .
HIV infection provides an invaluable landscape for studying colonization resistance owing to its profound effect on both adaptive and innate immunity. However, studies have been limited by the technical challenge of exploring the enormously complex microbiome, until recently, when advances in high-throughput sequencing technology have made it possible to accurately monitor changes in the entire microbiota by examining the presence and abundance of every microbial taxon in the microbiome. This new technology has revealed that the distal gut (colorectal) microbiome, the focus of most studies, is enriched with Proteobacteria but depleted in Firmicutes and Bacteroidetes after HIV or simian HIV infections, similar to the profile observed in inflammatory conditions [9] [10] [11] . At the genus level, HIV infection is characterized by enrichment of endogenous bacteria with disease-causing potential at the cost of depleting commensal bacteria [12] [13] [14] [15] . The dysbiotic distal gut microbiome, although not directly linked to obvious opportunistic infections, is strongly associated with microbial translocation, immune activation, and viral persistence [9, 10, 13, [16] [17] [18] [19] .
Clinical manifestations of proximal gut pathology -such as dyspepsia, nausea, vomiting -have long been observed in HIV-1-infected individuals [20, 21] . A range of opportunistic infections different from those in the distal gut has also been recognized [22] . Before the advent of combination antiretroviral therapy, 50-93% of all patients with HIV disease experienced gastrointestinal symptoms over the course of their illness [23, 24] . Furthermore, opportunistic infections still occur, albeit at a lower rate, despite the use of HAART and normalized CD4 þ cell counts [25] [26] [27] [28] . Clinically, our knowledge of opportunistic pathogens in relation to HIV-related proximal gut problems is rather limited, and clinical signs and symptoms alone rarely suggest a specific cause. Besides the distal gut microbiome, high-throughput sequencing has been used to examine the effects of HIV infection on the microbiomes in the vagina [29] [30] [31] , lung [32] , mouth [33, 34] , semen [35] , and anus [36] as well as in normally sterile body sites such as the brain [37] and blood [38, 39] , but not in the proximal gut. Unlike its distal counterpart, the status of microbiome in the proximal gut in HIV infection was only examined recently by analysis of gastric juice samples from only two HIV patients [40] . The absence of related studies reflects, in part, the difficulty of obtaining samples from the proximal gut. These can only be obtained using specialized endoscopic procedures. As such, the effect of HIV infection on the proximal gut microbiome is essentially unknown and most of the clinical complaints related to the proximal gut are simply interpreted as resulting from idiopathic HIV enteropathy. Given the lack of knowledge about the pathogens responsible for HIV enteropathy, treatment is limited to supportive measures, such as HAART, nutritional supplementation, and electrolyte replacements [41] .
Our working hypothesis is that proximal gut dysbiosis occurs in HIV patients when their CD4 þ cell counts drop below the normal level.
Materials and methods

Patient recruitment
The study was approved by the Institutional Review Board of the New York University School of Medicine (protocol number: 07-927). All participants provided written informed consent. Eight HIV-1-infected individuals and eight HIV seronegative controls were recruited from the participants in the New York University HIV Preventive Outreach Program and the New York University Bluestone Center for Clinical Research at the College of Dentistry during the period between 2008 and 2012. The HIV-negative controls were healthy volunteers without gastrointestinal problems unrelated to HIV infection. HIV-negative controls undertook esophagogastroduodenoscopy in the same endoscopy suites with HIV-infected patients. All patients, including both HIV-infected patients and HIV-negative controls were from New York metropolitan area.
Sample collection
Microbiome sampling was conducted in an endoscopy room. First, the oral cavity was sampled by swabbing the anterior tongue using a sterile Catch-All Sample Collection Swab (Epicentre Biotechnologies, Madison, Wiscosin, USA) according to manufacturer's instruction. The procedures for sampling the proximal gut were performed during esophagogastroduodenoscopy with modifications to minimize cross contamination, similar in principle to the previously described method used to study esophageal microbiome in gastroesophageal reflux disorders [42] . In brief, a sterile disposable cytology brush (Cook Medical, Bloomington, Indiana, USA) was inserted through the biopsy channel of the endoscope to brush mucosa in the order of the esophagus (2 cm above the squamocolumnar junction), stomach corpus, and duodenum, to minimize contamination from downstream organs. After removal of the cytology brush from each sampling, the biopsy channel was washed with 25 ml sterile water to minimize contamination by upstream organs. As backups, tissue biopsy samples and mucosal wash samples were also obtained.
DNA extraction and PCR amplification DNA was extracted from the specimens using a modified Qiagen DNA extraction method, as previously described [42] . From the extracted DNA, the V3 and V4 regions of bacterial 16S ribosomal RNA (rRNA) genes were amplified using the primer set 347F 5 0 -GGAGGCAG-CAGTRRGGAAT and 803R 5 0 -CTACCRGGG-TATCTAATCC, which we previously designed [43] . PCR reactions were carried out as previously described [42] and the amplicons were sequenced on the 454 FLX platform. A few mucosal samples that did not yield sufficient DNA for PCR amplification were replaced with either tissue biopsy samples or mucosal wash samples. Three types of negative controls were included to detect exogenous contamination: Template negative controls (PCR reaction without DNA template) along with the samples from HIV-positive and negative patients while constructing 16S PCR amplicon libraries; Specimen-negative controls (use water in lieu of a human specimen) along with the samples from HIV-positive and negative patients while extracting DNA from the human samples. Disease-negative controls (HIV-negative) that were run under the same PCR and sequencing condition as the samples from HIV-positive patients.
Bioinformatics analysis
The preprocessed sequences were grouped into operational taxonomic units and were classified to taxonomic levels from the phylum to genus levels using the Quantitative Insights Into Microbial Ecology (QIIME) pipeline [44] and/or Ribosomal Database Project II [45] . Taxa also were grouped based on tinctorial properties of bacteria (gram-positive or gram-negative), as previously described [42] . a-Diversities in cases and controls were compared by t-test with Monte Carlo permutations using compare_alpha_diversity.py, a built-in function in the QIIME pipeline. Principal coordinate plots were used to visualize sample separations based on unweighted UniFrac distances matrices [46] , with statistical significances calculated by the analysis of similarity method in QIIME. To identify bacterial taxa that consistently explained the differences between HIV patients and controls, the sequence data were compared using the linear discriminant analysis (LDA) effect size (LEfSe) method [47] .
Statistical analyses
Prevalence of a specific taxon in cases and controls, defined as the number of patients found to contain the taxon compared with the total number of patients in a group, was compared by Pearson's chi-squared test or Fisher exact test. Comparison of median relative abundance of a particular taxon between cases and controls were done by using the nonparametric Mann-Whitney U test. Coexistence between taxa was analyzed by linear regression. The strength and direction of the linear relationship between CD4 þ T-cell counts and bacterial abundance was assessed using nonparametric Spearman's rank correlation coefficients.
Results
We examined the status of colonization resistance in the proximal guts in eight HIV-1 patients and eight HIVnegative patients (Supplementary Table 1 , http://links. lww.com/QAD/A814). For HIV-negative patients, seronegative status was confirmed using the OraQuick ADVANCE Rapid HIV-1/2 antibody test. None of the HIV-infected patients had received HAART 6 month prior to specimen collection or antibiotics within the previous 8 weeks, except one patient who was on penicillin for syphilis. Samples were collected by brushing the mucosa of the esophagus, stomach, duodenum, and mouth of each patient, with a total of 63 samples acquired after excluding one gastric sample that failed to yield PCR products. The mouth was included as a reference site to contrast changes in the proximal gut. Microbiome analysis was done by universal 16S rRNA PCR coupled with sequencing using the 454 FLX technology, with an average of 5090 sequence reads yielded per sample. The template-negative control and specimen-negative control did not generate any visible PCR products after 30 cycles of amplification using the universal bacterial 16S rRNA primers.
HIV infection was associated with global alteration of the proximal gut microbiome especially that of the duodenal microbiome We first assessed a diversity of the proximal gut microbiome and found no significant difference in the diversity between HIV patients and controls in the proximal gut as a whole or in each of the three proximal gut sites (esophagus, stomach, or duodenum) in either Shannon diversity index or evenness index (P > 0.05). b-Diversity by principal coordinates analysis using unweighted UniFrac distance metrics showed an overall separation tendency of the samples among the four body sites, including the mouth (P ¼ 0.001) ( Fig. 1a ) as well as among the three proximal gut sites tested (P ¼ 0.001) ( Fig. 1b) . Analyses comparing HIV patients and controls showed that differential dispersion of samples was unclear when all four body sites were included in the analysis (P ¼ 0.088) ( Fig. 1c ), but became significant when the proximal gut was analyzed alone (P ¼ 0.023) ( Fig. 1d ). In site-specific analyses, separation between HIV patients and controls was significant in the duodenum (P ¼ 0.039) ( Fig. 1e ) but ambiguous in each of the three other body sites examined (P > 0.05) ( Fig. 1f-h) . These results suggest that HIV infection mainly affected the duodenal microbiome but the small effect size (r ¼ 0.101) indicating the necessity for detailed analyses based on individual taxa.
HIV infection abolished colonization resistance to exogenous Proteobacteria and altered the endogenous microbiome in the proximal gut Among the five major phyla in the proximal gut ( Fig. 2a ), HIV infection depleted Firmicutes (median relative abundance 43.61 vs. 65.81%, P ¼ 0.005) accompanied by an enrichment of Proteobacteria (11.77 vs. 6.28%, P ¼ 0.020), without any significant impact on relative abundances of Bacteroides (P ¼ 0.848), Actinobacteria (P ¼ 0.469), and Fusobacteria (P ¼ 0.083) ( Fig. 2c ). In comparison, Bacteroidetes was significantly enriched in the mouth (32.05 vs. 20.42%, P ¼ 0.049) in HIV infection ( Fig. 2b and d ). Using linear discriminant analysis effect size with LDA score >4 as the cutoff [47] , we found that in the proximal gut, HIV infection enriched four genera, including three genera in Proteobacteria-Burkholderia (0.35 vs. 0%, P < 0.0001), Bradyrhizobium (0.11 vs. 0%, P < 0.0001), and Ralstonia (0.16 vs. 0%, P ¼ 0.001)and one genus in Fusobacteria-Fusobacterium (3.92 vs. 0.94%, P ¼ 0.049), and depleted one genus in Firmicutes-Lactobacillus (0 vs. 0.09%, P ¼ 0.003) ( Fig. 3a and c) . HIV infection also enriched Prevotella (22.64 vs. 7.85%, P ¼ 0.050) in the mouth ( Fig. 3b and d ). Of particular interest were Burkholderia and Bradyrhizobium, which invaded the proximal guts of the majority (5/8) of HIV patients but were absent or very rare (1/7 in the stomach and 0/8 in other sites) in the guts of controls. Detailed analyses demonstrated that Burkholderia and Bradyrhizobium were represented by B. fungorum and B. pachyrhizi at the species level, respectively (Supplementary results, Supplementary Figure 1 and Supplementary Table 2 , http://links.lww.com/QAD/A814).
Burkholderia fungorum and Bradyrhizobium pachyrhizi selectively invaded the three proximal gut sites in HIV-infected patients Site-specific analyses indicated that the duodenum was pachyrhizi colonized the majority (5/8) of HIV patients, albeit at lower abundance than in the duodenum, but were virtually absent (1/7) in controls ( Fig. 4b) . Moreover, Ralstonia was enriched in HIV patients (0.79 vs. 0.01%, P ¼ 0.040) and was also found to colonize the controls. In the esophagus, none of the five taxa differed in abundance between HIV patients and controls although B. fungorum, B. pachyrhizi, and Ralstonia were exclusively present in 50% (4/8) of HIV-infected patients but none of the controls (Fig. 4c) . Fusobacterium, although informative of HIV status in the proximal gut ( Fig. 3c ) was not significantly different between HIV-infected patients and controls when the three proximal gut sites were analyzed separately ( Fig. 4) .
Burkholderia fungorum coexisted with Bradyrhizobium pachyrhizi in HIV infection
We observed a clear coexistent relationship between B. fungorum and B. pachyrhizi, with their concordant presence (n ¼ 14) and absence (n ¼ 9) observed in nearly all samples (23/24) from the proximal gut in HIV patients. Both species mainly colonized the duodenum with a decreasing abundance along the direction from the duodenum to stomach to esophagus (Fig. 5a-c) . When present, B. fungorum always outnumbered B. pachyrhizi at a ratio of approximately 15 : 1 (P < 0.0001, r 2 ¼ 0.956) (Fig. 5c ).
Both species appeared to be mostly confined to the HIV-infected proximal gut, since B. fungorum was only found in the proximal gut of HIV patients and B. pachyrhizi was detected in one of the seven gastric samples from the controls and one of the eight oral samples in HIV-infected patients (Fig. 4) . Lactobacillus species appeared to have a co-avoidant relationship with B. fungorum and B. pachyrhizi in the duodenum, given that both B. fungorum and B. pachyrhizi were absent in any of the six Lactobacillus-positive samples and conversely Lactobacillus were absent in any of the five samples positive for B. fungorum and B. pachyrhizi (Fig. 4a ). Figure 3c , http://links.lww. com/QAD/A814). Qualitatively, patients with normal CD4 þ cell counts (n ¼ 2) were resistant to colonization by B. fungorum and B. pachyrhizi, whereas those with low CD4 þ cell counts (<500 cells/ml) (n ¼ 6) lost the resistance except for a patient who received antibiotics for syphilis. Interestingly, the patient most enriched with B. fungorum (48.4%) and B. pachyrhizi (2.98%) in the duodenum had the lowest CD4 þ cell count (12 cells/ml).
Abundances of
Lactobacillus and Prevotella showed no correlation with CD4 þ cell counts in any of the four body sites analyzed (P > 0.05) and none of the six taxa analyzed showed any correlation of their abundance in the mouth with CD4 þ cell counts ( Supplementary Figure 3d , http://links.lww. com/QAD/A814). Correlation with the CD4 þ /CD8 þ ratio appeared to depend on CD4 þ cell counts, because the pattern of correlation with CD4 þ /CD8 þ was similar, albeit narrowed, to that with CD4 þ (Supplementary Table 3 , http://links.lww.com/QAD/A814). None of the six taxa showed any correlation of their abundance in any of the four body sites with CD8 þ T-cell counts or viral loads (P > 0.05).
Discussion
In this first study specially designed to determine the status of colonization resistance in the proximal gut, we systemically examined mucosal bacterial communities in all three major organs of the proximal gut: the esophagus, stomach, and duodenum. Globally, HIV infection enriched phyla Proteobacteria and depleted Firmicutes. This type of global change appears to be a programed reaction as similar changes have also been observed in the distal gut in HIV infection [10, 14, 48, 49] . At the species and genus levels, we found HIV infection abolished colonization resistance to certain exogenous bacteria and weakened the normal control of endogenous bacterial community.
The unique finding in the proximal gut was the consensus loss of colonization resistance to two exogenous bacterial species: B. fungorum and B. pachyrhizi among HIV patients who had low CD4 þ T-cell counts. Our data indicate that the likelihood that they constitute a significant portion of the endogenous normal microbiome is very low. Given the prior knowledge that the normal bacterial counts in the duodenum are in the order of 100 colony-forming units/ml [50] , we probably had sampled nearly all bacteria in the proximal gut site with the sequencing depth at approximately 5090 reads/sample in the present study. If they were endogenous bacteria the high throughput sequencing would have identified their presence in the samples from normal controls.
The sources of these two bacterial species were not identified, but our data suggest that the limiting factor that determines their colonization is the condition in the proximal gut rather than exposure to a special source that harbors these bacteria. Based on the prior knowledge, we know that they are commonly present in the environment. In the present study we found that they were unable to establish a detectable colonization in the normal proximal gut but the resistance to their colonization disappeared when the CD4 þ cell counts dropped to below the normal limit in HIV infection. The bacteria do not seem related to oral sex as they were not present in the oral cavity as shown in the present study and were not reported to be present in the vagina by previous studies [29] [30] [31] . A food or environmental contaminant was unlikely as all patients, including both HIV-infected patients and HIV-negative controls were from New York metropolitan area.
The observed association of B. fungorum and B. pachyrhizi with HIV infection was consistent with true colonization rather than transitory exposure or contamination because of the following nonrandom patterns. Their pattern of distribution in the four body sites examined exhibited a clear tropism favoring the proximal gut over the mouth. Within the proximal gut, the both species were more abundant in the duodenum, the most deeply located and least likely to be contaminated organ by an environmental source, with a decreasing gradient toward the esophagus.
In the duodenum, the distribution of these two species among HIV patients were selective, that is, present in every HIV patient who had abnormal CD4 þ T-cell counts (not on antibiotic therapy) but absent in all patients whose CD4 þ cell counts were normal. B. fungorum virtually coexisted with B. pachyrhizi and maintained a ratio of approximately 15 to 1. The absence of Burkholderia and Bradyrhizobium in the template-negative control, specimen-negative control, and disease-negative control essentially ruled out the possibility of environmental contamination since both controls and disease samples would have been equally affected if contamination had occurred.
Little is known about the mechanisms that govern colonization resistance in the proximal gut. However, studies from the distal gut indicate that both endogenous bacteria and host immune system play critical roles. For example, facultative anaerobic Proteobacteria are normally suppressed by metabolic exclusion caused by intense competition with obligate anaerobes Clostridia and Bacteroidia for fermentable carbohydrates in an anaerobic environment [10] . On the other hand, Proteobacteria often becomes a dominant component of the distal gut microbiome during inflammation when nitrate released from the host, unusable by obligate anaerobes, lifts the suppression by serving as an alternative energy source in oxidative phosphorylation for facultative anaerobes [14, 48, 49, 51] . Another mechanism potentially responsible for the shift of bacterial communities from obligate to facultative anaerobes could be the oxygen stress during inflammation from the formation of reactive intermediates, such as reactive oxygen and nitrogen species [52] [53] [54] . Infection with HIV causes inflammation of the human duodenum, given that most of the genes upregulated are involved in inflammatory reactions; these include T-cell genes (CD8A, CD5, TNFSF10), interferon-induced genes (RSAD2, OAS2, IFI44, IFITM, HLA-C, HLA-DRB1), and complements [55] . [56, 60] . It is also endosymbiotic with the white-rot fungus Phanerochaete chrysosporium, which is a saprophytic fungus capable of organic breakdown of the woody part of dead plants [61] . Besides this study, B. fungorum has been isolated from humans on four occasions, all from extraintestinal sites. The only clinically significant infection reported was bacteremia with B. fungorum in a 9-year-old girl with septic arthritis [62] . The other three isolates were from the vaginal secretions of a pregnant woman with candida vaginitis and preterm labor, the cerebrospinal fluid of a 66-year-old woman, and the respiratory secretion of a cystic fibrosis patient, respectively, but the clinical significance could not be determined because of the lack of clinical data [56, 63] . In a bioinformatics analysis, B. fungorum was linked to the origin of anti-ds DNA antibodies in systemic lupus erythematosus based on epitope mimicry [64] . B. pachyrhizi is a symbiotic, root nodulating bacterium inhabiting tuberous root-producing legume Pachyrhizus [22] . There are very few publications about this species, none of which are related to colonization/infection in humans or animals. In the present study, two of the five HIV patients colonized by these two species and one of three uncolonized HIV patients had watery diarrhea. Although both the colonized patients were different from the uncolonized patient by having an additional upper gastrointestinal symptom (nausea and vomiting), available information is inadequate for drawing a conclusion. Their downstream effects on HIV pathogenesis and contributions to clinical diseases need further studies, especially in those with advanced stage of disease.
The limitations pertinent to this study are related to the small sample size and the exploratory nature. We considered the limitation of the small sample size when we analyzed the data. In particular, we tried to minimize the chance of false positive findings by filtering out any differences whose effect size were less than four orders of magnitude (LDA score >4 as the cutoff) when comparing the cases and controls using the linear discriminant analysis (LDA) effect size method. We also strengthened the study by including the other relevant body sites besides the duodenum in the study, which revealed similar distributions for these two bacterial taxa in the stomach and esophagus. However, it cannot be entirely ruled out that the positive findings were by chance in this small study. Our study had a low statistical power typical of a small study that was insufficient for detection of all effects that are truly present (false negativity or type-II errors) unless the effect sizes were large. The small sample size also limited our capability of stratifying factors other than HIV infection (such as sex, race, and HIV progression) for their contribution to difference observed between cases and controls. Thus, a large-scale study is needed to reach more comprehensive conclusions.
